AIX 9.01 ▲0.33% ALU 0.88 ▼-2.22% DN1 99.70 ▼-0.09% EMUCA 0.89 KIT 1.90 ▲0.00% KKC 2.11 ▲0.00% LF1 1.92 ▲0.79% MBG 0.14 ▲0.00% MRE 1.88 ▼-0.53% PCI 1.09 ▼-0.91% PCX 1.99 ▼-0.75% RF1 3.52 ▼-0.28% SET 2.14 ▼-0.47% TET 0.22 ▼-2.22% WMX 1.69 ▼-1.17% BST 0.30 ▲3.45% CTS 0.56 ▲1.82% EFR 0.00 ▲0.00% AIX 9.01 ▲0.33% ALU 0.88 ▼-2.22% DN1 99.70 ▼-0.09% EMUCA 0.89 KIT 1.90 ▲0.00% KKC 2.11 ▲0.00% LF1 1.92 ▲0.79% MBG 0.14 ▲0.00% MRE 1.88 ▼-0.53% PCI 1.09 ▼-0.91% PCX 1.99 ▼-0.75% RF1 3.52 ▼-0.28% SET 2.14 ▼-0.47% TET 0.22 ▼-2.22% WMX 1.69 ▼-1.17% BST 0.30 ▲3.45% CTS 0.56 ▲1.82% EFR 0.00 ▲0.00%

S66 Star Combo Pharma Limited

Consumer Defensive · Household & Personal Products · website
$0.13
52wk 0.11 – 0.28
Overall
Value
Growth
Health
Quality
Momentum
Dividend
Price
About Star Combo Pharma Limited

Star Combo Pharma Limited manufactures and distributes health food products and nutritional supplements in Australia and China. It operates in two segments, OEM and Retail. The company develops, manufactures, markets, and sells natural health supplements and skin care products. It also provides its products through e-commerce platform to Chinese health product consumers. The company sells its products under the Costar, Living Healthy, Amax, and J&K brands. Star Combo Pharma Limited was founded in 2004 and is based in Smithfield, Australia.

Fundamental trends
Financial statements
Loading…
Key metrics
Market cap
$17.56M
P/E (trailing)
3.25
P/E (forward)
EPS (trailing)
0.04
Dividend yield
2.9%
Payout ratio
9.3%
Beta
0.34
EV / EBITDA
0.56
Price / Book
0.46
ROE
14.9%
Operating margin
1.4%
Net margin
22.4%
Total cash
$18.18M
Total debt
$4.30M
Current ratio
6.64
Debt / Equity
0.11
Free cash flow
$3.32M
Avg volume
26,287
Latest annual results (FY ending 30 Jun 2025)
  • Revenue
  • Gross profit
  • Operating income
  • Net income
  • Diluted EPS0.04
  • Free cash flow
  • Net debt
Sector peers (Consumer Defensive)
TickerMkt cap P/EScore
WOW $49.03B 81.9
COL $32.60B 31.9
EDV $6.32B 16.8
A2M $4.98B 26.4
TWE $4.21B
MTS $3.40B 12.4
BGA $1.88B 204.7
CBO $1.57B 32.8